alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document

Exhibit 4.2














July 1, 2021


Wilmington Trust Company
Rodney Square North
1100 North Market Street
Wilmington, DE 19890-0001
Attention:  Corporate Trust Administration


Park National Corporation
50 North Third Street
Newark, OH 43055


David L. Trautman
Brady T. Burt
Matthew R. Miller
c/o Park National Corporation
50 North Third Street
Newark, OH 43055


Re:       Notice of Resignation of Administrative Trustee and Appointment of Successor 


Ladies and Gentlemen:


The following notice is given pursuant to Section 8.11 of the Amended and Restated Trust Agreement for Vision Bancshares Trust I (the “Trust”), dated as of December 5, 2005 (the “Trust Agreement”).


We make reference to the Junior Subordinated Indenture, dated as of December 5, 2005 (the “Indenture”), originally between Vision Bancshares, Inc., an Alabama corporation (the “Predecessor Company”), and Wilmington Trust Company, a Delaware banking corporation (the “Trustee”), the First Supplemental Indenture, dated to be effective as of 6:00 p.m., Eastern Standard Time, on March 9, 2007, among Park National Corporation, an Ohio corporation (the “Company”), the Predecessor Company and the Trustee, and the Trust Agreement.  


With immediate effect, in connection with his retirement as an executive officer and an employee of the Company, effective June 30, 2021, and as evidenced by his signature below, C. Daniel DeLawder hereby resigns the position of Administrative Trustee of the Trust.   










The Company hereby appoints Matthew R. Miller to serve as a successor Administrative Trustee of the Trust (the “Successor Administrative Trustee”), and the Successor Administrative Trustee hereby accepts appointment to such position, from and after the date and time of this notice, as evidenced by his signature below.


Capitalized terms used herein and not otherwise defined are used as defined in the Trust Agreement.  This Notice of Resignation of Administrative Trustee and Appointment of Successor may be executed in several counterparts, each of which shall be an original and all of which shall constitute one and the same instrument.


                        This Notice of Resignation of Administrative Trustee and Appointment of Successor is given and made and is effective as of 8:00 a.m., Eastern Daylight Time, on July 1, 2021.


									
	RESIGNING ADMINISTRATIVE TRUSTEE:		
			
	By:  /s/ C. Daniel DeLawder		
	Name: C. Daniel DeLawder 		
			
	SUCCESSOR ADMINISTRATIVE TRUSTEE:		
			
	By:  /s/ Matthew R. Miller		
	Name: Matthew R. Miller		
			
			
	CURRENT ADMINISTRATIVE TRUSTEES:		
			
	By:  /s/ David L Trautman		By:  /s/ Brady T. Burt
	Name: David L. Trautman		Name: Brady T. Burt
			
			
	PARK NATIONAL CORPORATION		
			
	By:  /s/ Brady T. Burt		
	Name:  Brady T. Burt		
	Title:    Chief Financial Officer
Jimmie Lee WALKER, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D17-0977

District Court of Appeal of Florida, Second District.

April 07, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Granted.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Agriculture

###### Forest Service

# AGENCY:

Forest Service, USDA.

# ACTION:

Notice; correction.

# SUMMARY:

                        The Forest Service published an Information Collection Request for Comment in the                         **Federal Register**                         of March 24, 2009. The document contained an incorrect e-mail address.                    

# FOR FURTHER INFORMATION CONTACT:

Lathrop Smith, Forest Management staff, at 202-205-0858. Individuals who use telecommunication devices for the deaf (TDD) may call the Federal Relay Service (FRS) at 1-800-877-8339 twenty-four hours a day, every day of the year, including holidays.

## Correction

                        In the                         **Federal Register**                         of March 24, 2009, (73 FR 12303), on page 12303, in the                         **ADDRESSES**                         section, correct the e-mail address to read:                    

# ADDRESSES:

Comments concerning this notice should be addressed to Director, Forest Management, 1400 Independence Avenue, SW., Mailstop 1103, Washington, DC 20250-1103.

                        Comments also may be submitted via facsimile to 202-205-1045 or by e-mail to:                         *urgent_removal@fs.fed.us*.                    

Dated: April 2, 2009.

Richard W. Sowa,

Acting Assistant Deputy Chief,  National Forest System.

 [FR Doc. E9-8026 Filed 4-8-09; 8:45 am]

BILLING CODE 3410-11-P
EXHIBIT 32
----------




                           CERTIFICATIONS OF
          CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
            PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
       PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
       ---------------------------------------------------------



     The following statement is provided by the undersigned to accompany
the Quarterly Report on Form 10-Q for the quarter ended September 30, 2007,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be
deemed filed pursuant to any provision of the Securities Exchange Act of
1934 or any other securities law:

     Each of the undersigned certifies that the foregoing Report on
Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the
information contained in the Form 10-Q fairly presents, in all material
respects, the financial condition and results of operations of JMB/245 PARK
AVENUE ASSOCIATES, LTD.





By: /s/ Patrick J. Meara          By: /s/ Gailen J. Hull
    ----------------------            ----------------------------
    Patrick J. Meara                  Gailen J. Hull
    Chief Executive Officer           Chief Financial Officer and
                                      Principal Accounting Officer
### Michigan Supreme Court Lansing, Michigan

Marilyn Kelly,
Chief Justice

Michael F. Cavanag h
Elizabeth A. Weave r

Maura D. Corriga n Robert P. Young, Jr. Stephen J. Markma n Diane M. Hathaway,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk December 21, 2009

y1214 

# Order

December 21, 2009

139444

PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee,

v SC: 139444 COA: 284271 Oakland CC: 2007-218266-FH MARA KATLYN JADE, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the June 16, 2009 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.
EX PARTE Carl D. HUTTO

1151280 (CR-15-0587)

Supreme Court of Alabama.

October 14, 2016

**DECISION WITHOUT PUBLISHED OPINION**

Cert. denied.
**FISCAL 2007 COMPENSATION**

 

*Named Executive Officer Compensation*

 

On January 18, 2007, the Board of Directors approved annual base salaries for fiscal 2007 to the Named Executive Officers as follows:

 

| **Officer**         | **Title**                                           | **Compensation** |
|---------------------|-----------------------------------------------------|------------------|
|                |                                                |             |
| Kenneth U. Kuk      | Chairman, President & Chief Executive Officer   | $507,500         |
| Scott H. DeLong III | Senior Vice President & Chief Financial Officer | $310,000         |
| Paul F. Kraemer     | Senior Vice President of Sales                      | $375,000         |
| Paul P. Moore       | Senior Vice President of Sales                      | $375,000         |
| Thomas D. Sass      | Senior Vice President of Underwriting/Risk          | $306,000         |

 

*Board of Directors Compensation*

 

The Corporation’s non-employee directors – John H. Flittie, James J. Ritchie, Robert L. Laszewski, and Dennis M. Mathisen - receive an annual retainer of $20,000 ($27,500 for Mr. Flittie who is the Chairman of the Audit Committee) paid quarterly.  The annual retainers are paid in quarterly installments of unrestricted Common Stock of the Corporation, valued on the fifth business day prior to the last calendar day of the quarter for which the payment is made.  Each non-employee director also receives cash fees of $1,500 for each Board and Committee meeting attended in person, and $750 for each meeting attended by telephone.  All of the Corporation’s directors are reimbursed for reasonable out-of-pocket expenses they incur in attending Board and Committee meetings.  Members of the Board who are also employees of the Corporation do not receive any additional compensation forserving on the Board.

 

The Corporation’s non-employee and employee directors are eligible to receive stock options, stock appreciation rights, performance shares, stock awards and/or restricted stock awards under the Corporation’s 2004 Equity Incentive Plan.

 

*2007 Incentive Compensation Plan*

 

The Corporation’s annual incentive compensation plans are normally approved in the first quarter of the calendar year.  As of the date the Corporation’s Form 10-K for 2006 was filed, the annual incentive compensation plan had not been finalized.
Fourth Court of Appeals

San Antonio, Texas

March 19, 2015

No. 04-15-00051-CV

IN THE INTEREST OF H.R.S., A Child,

From the 81st Judicial District Court, Atascosa County, Texas

Trial Court No. 14-01-0013-CVA

Honorable Melissa Uram-Degerolami, Judge Presiding

ORDER

The Appellant’s First Motion for Extension of Time to File Brief is GRANTED. The

appellant’s brief is due on March 26, 2015.

_________________________________

Marialyn Barnard, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 19th day of March, 2015.

___________________________________

Keith E. Hottle

Clerk of Court
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 1214 Introduced in Senate (IS)]

<DOC>

118th CONGRESS
  1st Session
                                S. 1214

 To set forth limitations on exclusive approval or licensure of drugs 
              designated for rare diseases or conditions.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 19, 2023

  Ms. Baldwin introduced the following bill; which was read twice and 
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

 
 To set forth limitations on exclusive approval or licensure of drugs 
              designated for rare diseases or conditions.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Retaining Access and Restoring 
Exclusivity Act'' or the ``RARE Act''.

SEC. 2. LIMITATIONS ON EXCLUSIVE APPROVAL OR LICENSURE OF ORPHAN DRUGS.

    (a) In General.--Section 527 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 360cc) is amended--
            (1) in subsection (a), in the matter following paragraph 
        (2), by striking ``same disease or condition'' and inserting 
        ``same approved use or indication within such rare disease or 
        condition'';
            (2) in subsection (b)--
                    (A) in the matter preceding paragraph (1), by 
                striking ``same rare disease or condition'' and 
                inserting ``same approved use or indication for which 
                such 7-year period applies to such already approved or 
                licensed drug''; and
                    (B) in paragraph (1), by inserting ``, relating to 
                the approved use or indication,'' after ``the needs'';
            (3) in subsection (c)(1), by striking ``same rare disease 
        or condition as the already approved drug'' and inserting 
        ``same use or indication for which the already approved or 
        licensed drug was approved or licensed''; and
            (4) by adding at the end the following:
    ``(f) Approved Use or Indication Defined.--In this section, the 
term `approved use or indication' means the use or indication approved 
under section 505 of this Act or licensed under section 351 of the 
Public Health Service Act for a drug designated under section 526 for a 
rare disease or condition.''.
    (b) Application of Amendments.--The amendments made by subsection 
(a) shall apply with respect to any drug designated under section 526 
of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bb), 
regardless of the date on which the drug was so designated, and 
regardless of the date on which the drug was approved under section 505 
of such Act (21 U.S.C. 355) or licensed under section 351 of the Public 
Health Service Act (42 U.S.C. 262).
                                 <all>
```
**Exhibit
      32.1**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350**


**AS
      ADDED BY**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report on Form 10-Q of QNB Corp. (the Company)
      for
      the period ended September 30, 2007, as filed with the Securities and Exchange
      Commission (the Report), I, Thomas J. Bisko, President and CEO of the Company,
      certify, pursuant to 18 U.S.C. §1350, as added by § 906 of the Sarbanes-Oxley
      Act of 2002, that this periodic report fully complies with the requirements
      of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that
      information contained in this report fairly presents, in all material respects,
      the financial condition and results of operations of the issuer.




Date:November 9, 2007
            By:
            /s/ Thomas J. BiskoThomas
                J. Bisko
              President and CEO




A
      signed
      original of this written statement required by Section 906, or other document
      authenticating, acknowledging, or otherwise adopting the signature that appears
      in typed form within the electronic version of this written statement required
      by Section 906 has been provided to QNB Corp. and will be retained by the
      Company and furnished to the Securities and Exchange Commission or its staff
      upon request.
EX PARTE Vincent LAMPKIN

1151333 (CR-15-0698)

Supreme Court of Alabama.

October 14, 2016

**DECISION WITHOUT PUBLISHED OPINION**

Cert. denied.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                       1,518,836
<SECURITIES>                                         0
<RECEIVABLES>                                    5,252
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                       4,380,288
<DEPRECIATION>                             (1,583,113)
<TOTAL-ASSETS>                               4,514,511
<CURRENT-LIABILITIES>                                0
<BONDS>                                      2,586,742
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   1,521,404
<TOTAL-LIABILITY-AND-EQUITY>                 4,514,511
<SALES>                                        326,553
<TOTAL-REVENUES>                               361,489
<CGS>                                          151,945
<TOTAL-COSTS>                                  209,850
<OTHER-EXPENSES>                                81,906
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              60,394
<INCOME-PRETAX>                                  9,339
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              9,339
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     9,339
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
[Federal Register Volume 83, Number 10 (Tuesday, January 16, 2018)]
[Notices]
[Page 2282]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00501]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[SEC File No. 270-61, OMB Control No. 3235-0073]


Proposed Collection; Comment Request

Upon Written Request Copies Available From: Securities and Exchange 
Commission, Office of FOIA Services, 100 F Street NE, Washington, DC 
20549-2736.

Extension:
    Form S-3.

    Notice is hereby given that, pursuant to the Paperwork Reduction 
Act of 1995 (44 U.S.C. 3501 et seq.), the Securities and Exchange 
Commission (``Commission'') is soliciting comments on the collection of 
information summarized below. The Commission plans to submit this 
existing collection of information to the Office of Management and 
Budget for extension and approval.
    Form S-3 (17 CFR 239.13) is a short form registration statement 
used by domestic issuers to register a public offering of their 
securities under the Securities Act of 1933 (15 U.S.C. 77a et seq.). 
Form S-3 takes approximately 472.49 hours per response and is filed by 
approximately 2,092 issuers annually. We estimate that 25% of the 
472.49 hours per response (118.12 hours) is prepared by the issuer for 
a total annual reporting burden of 247,107 hours (118.12 hours per 
response x 2,092 responses).
    Written comments are invited on: (a) Whether this proposed 
collection of information is necessary for the proper performance of 
the functions of the agency, including whether the information will 
have practical utility; (b) the accuracy of the agency's estimate of 
the burden imposed by the collection of information; (c) ways to 
enhance the quality, utility, and clarity of the information collected; 
and (d) ways to minimize the burden of the collection of information on 
respondents, including through the use of automated collection 
techniques or other forms of information technology. Consideration will 
be given to comments and suggestions submitted in writing within 60 
days of this publication.
    An agency may not conduct or sponsor, and a person is not required 
to respond to, a collection of information unless it displays a 
currently valid control number.
    Please direct your written comment to Pamela Dyson, Director/Chief 
Information Officer, Securities and Exchange Commission, c/o Remi 
Pavlik-Simon, 100 F Street NE, Washington, DC 20549 or send an email 
to: <a href="/cdn-cgi/l/email-protection#48181a0917052921242a2730083b2d2b662f273e"><span class="__cf_email__" data-cfemail="9dcdcfdcc2d0fcf4f1fff2e5ddeef8feb3faf2eb">[email protected]</span></a>.

    Dated: January 9, 2018.
Eduardo A. Aleman,
Assistant Secretary.
[FR Doc. 2018-00501 Filed 1-12-18; 8:45 am]
 BILLING CODE 8011-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXHIBIT 32.1
                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


      In connection with the Annual Report of Lakeside Mortgage Fund, LLC (the
"Company"), on Form 10-KSB for the fiscal year ended December 31, 2006, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, William F. Webster, President and Chief Executive Officer of Lakeside
Financial Group, Inc., the Manager of the Company, certify, pursuant to 18
U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to my knowledge:

      (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
      (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.


Dated: March 29, 2007                             /S/  William F. Webster
                                                  ------------------------------
                                                  William F. Webster,
                                                  President of Manager
                                                  Lakeside Financial Group, Inc.
Lakida Marchae CLARK, Appellant, v. STATE of Florida, Appellee.

No. 1D17-2938

District Court of Appeal of Florida, First District.

January 11, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.